Fusion

FAB.L

Tags: GB Healthcare Biotechnology

Fusion Antibodies plc Price (FAB.L)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

55,556,020

(113.5542)%

Market Cap of Fusion (FAB.L)

Market cap:

As of , FAB.L has a market cap of . This makes FAB.L the 1116th most valuable company in the GB by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceu... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $2.8-12
Market Cap 6.48M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Dr. Adrian Robert Kinkaid Ph.D.
IPO Date: December, 18, 2017
Country: GB
Currency: GBp
Headquaters: No Data
Employees: 27

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: